Long-Term Follow-up of the First Randomized Trial Using Neoadjuvant Chemotherapy in Stage Ib Squamous Carcinoma of the Cervix: The Final Results

By Sardi J.E.   Giaroli A.   Sananes C.   Ferreira M.   Soderini A.   Bermudez A.   Snaidas L.   Vighi S.   Rueda N.G.   di Paola G.  

Gynecologic Oncology, Vol. 67, Iss. 1, 1997-10 ,pp. : 61-69

Elsevier

Access to resources Recommend Favorite

Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065)

By                        

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 487-493

Spandidos Publications

Access to resources Recommend Favorite

MIB-1 Labeling Index as a Prognostic Indicator for Survival in Patients with FIGO Stage IB Squamous Cell Carcinoma of the Cervix

By Ho D.M.-T.   Hsu C.-Y.   Chiang H.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 97-102

Elsevier

Access to resources Recommend Favorite

A Comparison of Prognoses of Pathologic Stage Ib Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix

By Nakanishi T.   Ishikawa H.   Suzuki Y.   Inoue T.   Nakamura S.   Kuzuya K.  

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 289-293

Elsevier

Access to resources Recommend Favorite

Laparoscopic Port-Site Recurrence Following Surgery for a Stage IB Squamous Cell Carcinoma of the Cervix with Negative Lymph Nodes

By Kohlberger P.D.   Edwards L.   Collins C.   Milross C.   Hacker N.F.  

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 324-326

Elsevier

Access to resources Recommend Favorite